Price T M, Strong D D, Rudee M L, Doolittle R F
Proc Natl Acad Sci U S A. 1981 Jan;78(1):200-4. doi: 10.1073/pnas.78.1.200.
Specimens of human fibrinogen mixed with Fab fragments of antibodies that were specific for various portions of the fibrinogen molecule were tungsten shadow-cast and examined by electron microscopy. Typical trinodular fibrinogen molecules were observed when Fab fragments were omitted or when fragments from nonimmune sera were used. In the experimental fibrinogen-Fab preparations, a significant number of molecules were found with an extra nodule. In the case of Fab fragments from antibodies directed to fragment E, the additional nodule was attached to the central sphere of the fibrinogen molecule. Similarly, anti-fragment D preparations yielded molecules that were derivatized on the terminal spheres. Fragments from antibodies raised against a cyanogen bromide fragment of fibrinogen alpha chains (residues 241-476) also led to exclusive derivatization of the terminal domains, although in these cases the additional material was often separated discretely from the terminal sphere by a gap. These experiments confirm longstanding notions that the central domain of a trinodular fibrinogen molecule corresponds to the plasmin-derived fragment E and that the terminal spheres correspond to fragments D. Moreover, the carboxy-terminal two-thirds of alpha chains protrude from the extremities of the molecule, as had been inferred on the basis of indirect biochemical data.
将与针对纤维蛋白原分子不同部位的抗体Fab片段混合的人纤维蛋白原标本进行钨阴影投射,并通过电子显微镜检查。当省略Fab片段或使用来自非免疫血清的片段时,观察到典型的三结节纤维蛋白原分子。在实验性纤维蛋白原 - Fab制剂中,发现大量分子有一个额外的结节。对于针对片段E的抗体的Fab片段,额外的结节附着在纤维蛋白原分子的中心球体上。同样,抗片段D制剂产生在末端球体上衍生化的分子。针对纤维蛋白原α链的溴化氰片段(残基241 - 476)产生的抗体片段也导致末端结构域的特异性衍生化,尽管在这些情况下,额外的物质通常通过间隙与末端球体离散分离。这些实验证实了长期以来的观点,即三结节纤维蛋白原分子的中央结构域对应于纤溶酶衍生的片段E,末端球体对应于片段D。此外,正如基于间接生化数据所推断的那样,α链的羧基末端三分之二从分子末端突出。